=========================================================================== * Cardiac MRI: Function and Viability * http://www.radreport.org/template/0000049 Type: Reporting template Language: English (en) Modified date: 2012-07-19 Creator: Jacobs JE, et al. Contributor: Kahn CE Jr [editor] Contributor: North American Society for Cardiac Imaging (NASCI) This file is part of the "RSNA Radiology Reporting Templates." The RSNA Radiology Reporting Templates are licensed without charge under the RSNA's license agreement (the "License"); you may not use this file except in compliance with the License (http://www.radreport.org/license.pdf). Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. Copyright (c) 2013, Radiological Society of North America, Inc. (RSNA) ALL RIGHTS RESERVED =========================================================================== Cardiac MRI: Function and Viability Indication: [ ] Comparison: [ ] Technique: [1.5 |3.0]T MRI Scanner. [Turbospin; gradient] echo imaging in [*axial and double oblique; axial; oblique] planes for anatomic definition. [*Short and long; short; long] axis cine imaging for evaluation of function and intravascular blood flow. Velocity phase imaging for quantification of flow in [*ascending aorta and pulmonary artery; ascending aorta; pulmonary artery]. [*Short and long; short; long] axis delayed enhanced imaging for delineation of myocardial scar and fibrosis using [] mL [Magnevist |Multihance |Optimark] gadolinium contrast. FINDINGS: Left ventricular Measurements: End Diastolic Diameter [] (normal: 36-56-mm) Ejection Fraction [ ]% (normal: male = 56-78%; female = 56-78%) Stroke Volume [ ] mL End Diastolic Volume [ ] mL (normal: male = 77-195 ml; female = 52-141 ml) Indexed End Diastolic Volume [ ]mL/meter2 End Systolic Volume [ ] mL (normal: male = 19-72 ml; female = 13-51 ml) Indexed End Systolic Volume [ ]mL/meter2 Cardiac Output [ ] L/min (normal: male = 2.82-8.82 l/min; female = 2.7-6.0 l/min) Cardiac Index [ ] L/min/meter2 (normal: male = 1.74-4.2 l/min/m²; female = 1.8-3.8 l/min/m²) Index values are normalized to a BSA of [.]. VALVE DISEASE Aortic Valve: [Normal|regurgitant|stenotic]. Aortic forward volume [] mL Aortic regurgitant volume [] mL [Aortic valve area: [ ]cm2; < 1.0 cm2 severe; 1.0-1.5 cm2 moderate; 1.5-2.0 cm2 mild; > 2.0 cm2 normal] Mitral Valve: [Normal|regurgitant|mildly stenotic|moderately stenotic|severely stenotic]. Mitral regurgitant volume [] mL Mitral regurgitant fraction [] %mL Ascending aorta [] mm Left atrial dimension [] mm (AP x 4-chamber) Left atrial area [] sq cm LEFT VENTRICLE REGIONAL WALL MOTION {0 = normokinetic, 1 = hypokinetic, 2 = akinetic, 3 = dyskinetic} Base anterior [0 | 1| 2| 3] anterolateral [0 | 1| 2| 3] inferolateral [0 | 1| 2| 3] inferior [0 | 1| 2| 3] inferioseptal [0 | 1| 2| 3] anteroseptal [0 | 1| 2| 3] Mid anterior [0 | 1| 2| 3] anterolateral [0 | 1| 2| 3] inferolateral [0 | 1| 2| 3] inferior [0 | 1| 2| 3] inferioseptal [0 | 1| 2| 3] anteroseptal [0 | 1| 2| 3] Apex anterior [0 | 1| 2| 3] lateral [0 | 1| 2| 3] inferior [0 | 1| 2| 3] septum [0 | 1| 2| 3] True apex [0 | 1| 2| 3] LEFT VENTRICLE MYOCARDIAL ENHANCEMENT [0 | 1| 2| 3| 4]{ 0 = none, 1 = 1-25%, 2 = 26-50%, 3 = 51-75%, 4 = 76-100%} Base anterior [0 | 1| 2| 3| 4] anterolateral [0 | 1| 2| 3| 4] inferolateral [0 | 1| 2| 3| 4] inferior [0 | 1| 2| 3| 4] inferioseptal [0 | 1| 2| 3| 4] anteroseptal [0 | 1| 2| 3| 4] Mid anterior [0 | 1| 2| 3| 4] anterolateral [0 | 1| 2| 3| 4] inferolateral [0 | 1| 2| 3| 4] inferior [0 | 1| 2| 3| 4] inferioseptal [0 | 1| 2| 3| 4] anteroseptal [0 | 1| 2| 3| 4] Apex anterior [0 | 1| 2| 3| 4] lateral [0 | 1| 2| 3| 4] inferior [0 | 1| 2| 3| 4] septum [0 | 1| 2| 3| 4] True apex [0 | 1| 2| 3| 4] Non-cardiac findings: [] IMPRESSION: 1. Global systolic LV function: [normal|mildly impaired|moderately impaired|severely impaired]. 2. LV viability: Viable myocardium in distribution of [left main, LAD, LCX, RCA] coronary artery, in region of wall motion abnormality. 3. Valvular disease: [Present|Absent] in aortic valve. [Present|Absent] in mitral valve.